首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers
【2h】

Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers

机译:麻疹-腮腺炎-风疹和水痘疫苗与第四剂b型流感嗜血杆菌和脑膜炎奈瑟氏球菌血清群C和Y-破伤风类毒素结合疫苗的免疫学和安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A pooled analysis was conducted of 1257 toddlers who received a fourth dose of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) or Hib conjugate vaccine (Hib polysaccharide conjugated to N. meningitidis outer membrane protein) coadministered with measles-mumps-rubella (MMR) and varicella (VAR) vaccines (/). Noninferiority of immunological responses to MMR and VAR was demonstrated between groups and incidences of MMR- and VAR-specific solicited symptoms were similar, indicating that HibMenCY-TT can be coadministered with MMR and VAR.
机译:对接受了第四剂流感嗜血杆菌b型脑膜炎奈瑟球菌血清群C和Y型破伤风类毒素结合疫苗(HibMenCY-TT)或Hib结合疫苗(Hib多糖与脑膜炎奈瑟氏球菌外膜蛋白结合的第四批疫苗)的1257名幼儿进行了汇总分析。 )与麻疹,腮腺炎,风疹(MMR)和水痘(VAR)疫苗共同给药。在各组之间证实了对MMR和VAR的免疫学反应的非劣效性,而且MMR和VAR特异性征状的发生率相似,这表明HibMenCY-TT可以与MMR和VAR并用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号